Semaglutide is a revolutionary GLP-1 receptor agonist that was originally developed for patients with Type 2 diabetes, but when physicians noticed how much weight their patients were losing, they began to study Semaglutide exclusively for weight loss. Clinic trials demonstrate that up to 90% of participants using Semaglutide lost at least 5% of their weight; 50% of participants lost 15%; and 30% of participants lost 20%. There is no other weight loss drug or plan on the market that compares. In June, 2022, the FDA approved Semaglutide for weight loss.

​

How does Semaglutide work?

Semaglutide acts like GLP-1 (a gut hormone) to:

- Increase insulin production

- Decrease glucagon synthesis

- Delay gastric emptying

- Suppress hunger. It signals your brain that you are full so you can lose weight without feeling like you are depriving yourself of calories.